The U.S. Food and Drug Administration announced launch of a new program to issue Commissioner's National Priority Vouchers or CNPVs, which shortens review time significantly, with a view to support national health priorities. The new CNPV program, which will begin in 2025, aims to accelerate the drug review process for companies while maintaining the FDA's rigorous standards for safety, efficacy..
from RTT - Top Story https://ift.tt/SjGIf1H
via IFTTT
from RTT - Top Story https://ift.tt/SjGIf1H
via IFTTT
Comments
Post a Comment